NCT01821703View on ClinicalTrials.gov

A Study of LY3045697 After Multiple Oral Dosing in Healthy Participants

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 31, 2013

Primary Completion Date

September 30, 2013

Study Completion Date

September 30, 2013

Conditions

Healthy Volunteers

Interventions

DRUG

LY3045697

Administered as oral solution

DRUG

Placebo

Administered as oral solution

DRUG

Spironolactone

Administered as capsule

DRUG

Placebo

Administered as capsule

Trial Locations (1)

9471 GP

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Zuidlaren

All Listed Sponsors

lead

Eli Lilly and Company

INDUSTRY

NCT01821703 - A Study of LY3045697 After Multiple Oral Dosing in Healthy Participants | Biotech Hunter | Biotech Hunter